Kiran Infertility Center Hyderabad
At Kiran Infertility Center, we know how emotionally demanding the IVF journey can be, especially when embryos do not implant as expected. To support better outcomes, we offer the Endometrial Receptivity Array (ERA) in Hyderabad, an advanced test that helps us determine the ideal moment for embryo transfer, giving each cycle the best chance for success.
The ERA test is a specialized diagnostic tool that identifies your personal “window of implantation”—the time when your uterine lining is most receptive to an embryo. By analyzing gene activity in a small endometrial tissue sample, the test reveals whether the lining is:
With this information, we can accurately time the embryo transfer, especially in cases of repeated implantation failure.
The ERA test may be recommended if you:
The procedure is generally safe. Some women may experience mild cramping or spotting, similar to a routine gynecological exam. Risks are minimal and rare.
At Kiran Infertility Center, we combine compassionate care and world-class fertility technology. As a trusted ERA testing center in Hyderabad, our team uses this advanced tool to individualize your IVF plan and support you at every step of your journey to parenthood.
Take the Next Step Towards Building Your Family
Every family-building journey is unique. Our experienced fertility team provides advanced diagnostic testing, personalised treatment planning and compassionate support to help identify the most appropriate approach for your individual IVF needs.
Our fertility team is here to answer your questions, discuss your treatment options, and provide the guidance and support you need throughout your family-building journey.
Email us at info@kiranivfgenetic.com to start the conversation.
The Endometrial Receptivity Array (ERA) is a diagnostic test designed to assess the receptivity of the uterine lining. It analyses gene activity in a small sample of endometrial tissue to help identify an individual's potential window of implantation and determine whether the endometrium is receptive, pre-receptive or postreceptive at the time of sampling.
The ERA test involves a minimally invasive endometrial biopsy to collect a small tissue sample from the lining of the uterus. The sample is then analyzed using molecular testing to evaluate markers associated with endometrial receptivity. The results may be used by the fertility team to help personalize the timing of a subsequent embryo transfer.
An ERA test may be considered for selected patients, particularly those who have experienced repeated implantation failure despite having good-quality embryos. Your fertility specialist will review your previous IVF history and individual circumstances to determine whether ERA testing may be appropriate for you.
The purpose of ERA testing is to provide information that may help personalize the timing of embryo transfer. However, it does not guarantee implantation or pregnancy, and the evidence regarding whether ERA improves live-birth rates for all IVF patients remains limited. Your fertility specialist can discuss the potential benefits and limitations in the context of your individual treatment.
The ERA test is generally considered a minimally invasive procedure. Some women may experience mild cramping or light spotting following the endometrial biopsy, similar to symptoms that can occur after a routine gynecological procedure. Your medical team will explain the procedure and any relevant risks before the test is performed.